Author:
Keller Thomas,Spece Laura J.,Donovan Lucas M.,Udris Edmunds,Coggeshall Scott S.,Griffith Matthew,Bryant Alexander D.,Casaburi Richard,Cooper J. Allen,Criner Gerard J.,Diaz Philip T.,Fuhlbrigge Anne L.,Gay Steven E.,Kanner Richard E.,Martinez Fernando J.,Panos Ralph J.,Shade David,Sternberg Alice,Stibolt Thomas,Stoller James K.,Tonascia James,Wise Robert,Yusen Roger D.,Au David H.,Feemster Laura C.
Funder
National Heart, Lung, and Blood Institute, National Institutes of Health
Department of Health and Human Services
Centers for Medicare and Medicaid Services
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference43 articles.
1. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis;Kew;Cochrane Database Syst Rev,2014
2. Tiotropium versus salmeterol for the prevention of exacerbations of COPD;Vogelmeier;N Engl J Med,2011
3. Tiotropium versus placebo for chronic obstructive pulmonary disease;Karner;Cochrane Database Syst Rev,2014
4. Indacaterol-glycopyrronium for COPD;Wedzicha;N Engl J Med,2016
5. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial;Calverley;Lancet Respir Med,2018
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献